These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37456242)

  • 41. Corrigendum: Exome Sequencing in BRCA1-2 Candidate Familias: The Contribution of Other Cancer Susceptibility Genes.
    Doddato G; Valentino F; Giliberti A; Papa FT; Tita R; Bruno LP; Resciniti S; Fallerini C; Benetti E; Palmieri M; Mencarelli MA; Fabbiani A; Bruttini M; Orrico A; Baldassarri M; Fava F; Lopergolo D; Rizzo CL; Lamacchia V; Mannucci S; Pinto AM; Currò A; Mancini V; ; ; ; ; Mari F; Renieri A; Ariani F
    Front Oncol; 2021; 11():740860. PubMed ID: 34485163
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Corrigendum: Differential Expression Analysis Revealing CLCA1 to Be a Prognostic and Diagnostic Biomarker for Colorectal Cancer.
    Wei FZ; Mei SW; Wang ZJ; Chen JN; Shen HY; Zhao FQ; Li J; Liu Z; Liu Q
    Front Oncol; 2020; 10():634122. PubMed ID: 33392101
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Corrigendum: Case report:
    Mauri G; Patelli G; Gori V; Lauricella C; Mussolin B; Amatu A; Bencardino K; Tosi F; Bonazzina E; Bonoldi E; Bardelli A; Siena S; Sartore-Bianchi A
    Front Oncol; 2023; 13():1147497. PubMed ID: 37056342
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Corrigendum: EXOSC5 as a Novel Prognostic Marker Promotes Proliferation of Colorectal Cancer via Activating the ERK and AKT Pathways.
    Pan H; Pan J; Song S; Ji L; Lv H; Yang Z
    Front Oncol; 2021; 11():670041. PubMed ID: 33898326
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Corrigendum: Establishment of Tumor Treating Fields Combined With Mild Hyperthermia as Novel Supporting Therapy for Pancreatic Cancer.
    Bai L; Pfeifer T; Gross W; De La Torre C; Zhao S; Liu L; Schaefer M; Herr I
    Front Oncol; 2022; 12():889215. PubMed ID: 35433483
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Corrigendum: Case report: A novel intergenic
    Wang SS; Wang F; Zeng Z; Gao F; Liu HH; Wang HN; Hu Y; Qin HF
    Front Oncol; 2022; 12():1113289. PubMed ID: 36582807
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Corrigendum: A Prospective Evaluation of Serum Vitamin D (1, 25(OH)
    Razak S; Alam I; Afsar T; Abulmeaty MMA; Almajwal A; Jahan S
    Front Oncol; 2020; 10():200. PubMed ID: 32161719
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinicopathological characteristics of mucinous and non-mucinous adenocarcinoma in the colon and rectum in Rajavithi Hospital, Thailand.
    Jivapaisarnpong P; Boonthongtho K
    J Med Assoc Thai; 2011 Mar; 94 Suppl 2():S41-5. PubMed ID: 21717877
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Corrigendum: ITGB5 promotes innate radiation resistance in pancreatic adenocarcinoma by promoting DNA damage repair and the MEK/ERK signaling pathway.
    Wen X; Chen S; Chen X; Qiu H; Wang W; Zhang N; Liu W; Wang T; Ding X; Zhang L
    Front Oncol; 2024; 14():1381151. PubMed ID: 38463236
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Corrigendum: Establishment of tumor treating fields combined with mild hyperthermia as novel supporting therapy for pancreatic cancer.
    Bai L; Pfeifer T; Gross W; De La Torre C; Zhao S; Liu L; Schaefer M; Herr I
    Front Oncol; 2024; 14():1343421. PubMed ID: 38487722
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Epidemiological study, pathologic evaluation and prognostic factors of colorectal mucinous vs non-mucinous adenocarcinoma (a series of 196 patients)].
    Arfaoui Toumi A; Kriaa Ben Mahmoud L; Khiari M; Lahmer A; Gharbi L; Dhraïef M; Khalfallah T; Regaya Mzabi S; Bouraoui S
    Tunis Med; 2010 Jan; 88(1):12-7. PubMed ID: 20415207
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Migration of mitochondrial DNA in the nuclear genome of colorectal adenocarcinoma.
    Srinivasainagendra V; Sandel MW; Singh B; Sundaresan A; Mooga VP; Bajpai P; Tiwari HK; Singh KK
    Genome Med; 2017 Mar; 9(1):31. PubMed ID: 28356157
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Corrigendum: Berberine and Oligomeric Proanthocyanidins Exhibit Synergistic Efficacy Through Regulation of PI3K-Akt Signaling Pathway in Colorectal Cancer.
    Okuno K; Garg R; Yuan YC; Tokunaga M; Kinugasa Y; Goel A
    Front Oncol; 2022; 12():952180. PubMed ID: 35847926
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Corrigendum to "Mucinous Histology,
    Harpaz N; Gatt YE; Granit RZ; Fruchtman H; Hubert A; Grinshpun A
    J Oncol; 2020; 2020():6725209. PubMed ID: 32963530
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Corrigendum: Prediction of EGFR Mutation Status Based on
    Yin G; Wang Z; Song Y; Li X; Chen Y; Zhu L; Su Q; Dai D; Xu W
    Front Oncol; 2021; 11():747316. PubMed ID: 34557420
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Corrigendum: Heparin binding epidermal growth factor-like growth factor is a prognostic marker correlated with levels of macrophages infiltrated in lung adenocarcinoma.
    Van Hiep N; Sun WL; Feng PH; Lin CW; Chen KY; Luo CS; Dung LN; Van Quyet H; Wu SM; Lee KY
    Front Oncol; 2022; 12():1106553. PubMed ID: 36582792
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Erratum: Sonographic Features of Pure Mucinous Breast Carcinoma With Micropapillary Pattern.
    Frontiers Production Office
    Front Oncol; 2021; 11():822462. PubMed ID: 34966692
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Corrigendum: Simultaneous Integrated Boost Intensity-Modulated Radiation Therapy Can Benefit the Locally Advanced Rectal Cancer Patients with Clinically Positive Lateral Pelvic Lymph Node.
    Li S; Zhang Y; Yu Y; Zhu X; Geng J; Teng H; Wang Z; Sun T; Wang L; Wang H; Li Y; Wu A; Cai Y; Wang W
    Front Oncol; 2021; 11():790945. PubMed ID: 34970497
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Corrigendum: Long non-coding RNA-TMPO-AS1 as ceRNA binding to let-7c-5p upregulates STRIP2 expression and predicts poor prognosis in lung adenocarcinoma.
    Wang J; Yuan Y; Tang L; Zhai H; Zhang D; Duan L; Jiang X; Li C
    Front Oncol; 2022; 12():1109637. PubMed ID: 36582796
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Corrigendum: Serum Biomarker Panel for Diagnosis and Prognosis of Pancreatic Ductal Adenocarcinomas.
    Mehta S; Bhimani N; Gill AJ; Samra JS; Sahni S; Mittal A
    Front Oncol; 2021; 11():774861. PubMed ID: 34692555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.